IL17A and Alzheimer disease: It has been hypothesized that high IL-22 and low IL-17 expression predominate during the chronic phase of AD; therefore, the initial hypothesis of AD as a Th2-driven disease should be modified with the addition of the Th22/Tc22 subsets associated with epidermal changes18.